Literature DB >> 6800680

Factors influencing hepatic glutathione concentrations: a study in surgical patients.

E C Shi, R Fisher, M McEvoy, R Vantol, M Rose, J M Ham.   

Abstract

1. Hepatic total glutathione (reduced plus oxidized) and oxidized glutathione levels were measured in operative wedge liver biopsy specimens obtained from 70 patients. 2. The effects on hepatic reduced glutathione (GSH) level of four potential risk factors (abnormal liver histology, abnormal preoperative tests fo liver function, drug ingestion and protein malnutrition) were examined. 3. Each of the four risk factors was associated with a significant reduction in hepatic GSH. Multivariate analysis indicated that only three of these risk factors (abnormal liver histology, drug ingestion and protein malnutrition) had independent effects in reducing hepatic GSH. 4. Twenty-five of the 70 patients studied did not have any of the four risk factors. The mean hepatic GSH level in these patients was 3.92 mumol/g of liver wet weight (SD 0.62), giving a 95% reference range of 2.71-5.14 mumol/g of liver net weight.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6800680     DOI: 10.1042/cs0620279

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  4 in total

Review 1.  Non-narcotic analgesics. Problems of overdosage.

Authors:  T J Meredith; J A Vale
Journal:  Drugs       Date:  1986       Impact factor: 9.546

2.  Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease. Evidence of lipid peroxidation.

Authors:  S Shaw; K P Rubin; C S Lieber
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

3.  Skeletal muscle glutathione after surgical trauma.

Authors:  J L Luo; F Hammarqvist; K Andersson; J Wernerman
Journal:  Ann Surg       Date:  1996-04       Impact factor: 12.969

4.  Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity.

Authors:  Julie Massart; Karima Begriche; Caroline Moreau; Bernard Fromenty
Journal:  J Clin Transl Res       Date:  2017-02-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.